I recommend waiting for a better discount before investing in Gossamer Bio Inc. (GOSS).

The price of Gossamer Bio Inc. (NASDAQ: GOSS) closed at $2.40 in the last session, up 14.29% from day before closing price of $2.10. In other words, the price has increased by $+0.3000 from its previous closing price. On the day, 5294995 shares were traded. GOSS stock price reached its highest trading level at $2.4400 during the session, while it also had its lowest trading level at $2.0700.

Top 5 Undervalued Stocks To Own In 2023

Microchip Maker Releases "World's Most Powerful Data Center CPU". It could allow the company who manufactures it to lead the industry as the global microchip shortage continues into the coming year. We've put together a free research report that explains all the details. Not only will you find out why analysts believe this chip manufacturer could lead the pack, you will also discover four more potential winners for the coming year.

Click here to download your Free Research Report…

Sponsored

Ratios:

We take a closer look at GOSS’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 5.90 and its Current Ratio is at 5.90. In the meantime, Its Debt-to-Equity ratio is 3.93 whereas as Long-Term Debt/Eq ratio is at 3.73.

Upgrades & Downgrades

Barclays Downgraded its Overweight to Equal Weight on December 07, 2022, whereas the target price for the stock was revised from $18 to $2.

Insider Transactions:

An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Oct 24 when Peterson Caryn sold 4,757 shares for $12.07 per share. The transaction valued at 57,431 led to the insider holds 61,415 shares of the business.

Carter Laura sold 4,876 shares of GOSS for $58,868 on Oct 24. The Chief Scientific Officer now owns 82,292 shares after completing the transaction at $12.07 per share. On Oct 24, another insider, Aranda Richard, who serves as the Chief Medical Officer of the company, sold 4,757 shares for $12.07 each. As a result, the insider received 57,431 and left with 205,430 shares of the company.

Stock Price History:

Over the past 52 weeks, GOSS has reached a high of $15.19, while it has fallen to a 52-week low of $1.57. The 50-Day Moving Average of the stock is 4.6996, while the 200-Day Moving Average is calculated to be 8.9850.

Shares Statistics:

According to the various share statistics, GOSS traded on average about 5.43M shares per day over the past 3-months and 4.11M shares per day over the past 10 days. A total of 91.18M shares are outstanding, with a floating share count of 89.93M. Shares short for GOSS as of Oct 13, 2022 were 17.66M with a Short Ratio of 26.89M, compared to 16.61M on Sep 14, 2022. Therefore, it implies a Short% of Shares Outstanding of 18.80% and a Short% of Float of 21.70%.

Earnings Estimates

The company has 12 analysts who recommend its stock at the moment. On average, analysts expect EPS of -$0.63 for the current quarter, with a high estimate of -$0.56 and a low estimate of -$0.84, while EPS last year was -$0.8. The consensus estimate for the next quarter is -$0.63, with high estimates of -$0.54 and low estimates of -$0.84.

Analysts are recommending an EPS of between -$2.57 and -$3.17 for the fiscal current year, implying an average EPS of -$2.75. EPS for the following year is -$2.49, with 12 analysts recommending between -$1.85 and -$3.41.